The call ran from 6:01 PM to 7:00 PM IST (59 min). Our summary is being written and will appear here.
The results behind this call
13:27 IST
BSE
Financial Results
Dr. Lal Pathlabs Q2 FY27 Results: Net Profit ₹193.9 Cr, Up 27.4% YoY
Dr. Lal Pathlabs Ltd reported revenue from operations of ₹873.9 Cr (+19.6% YoY) and net profit of ₹193.9 Cr (+27.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹193.9 Cr · +27.4% YoY
What management said last time
Full summary →From the call summary published .
Outlook they gave
FY27 revenue guidance of early to mid-teens (13-15%). Capex planned at ₹100-120cr for labs and radiology.
Growth they described
Q4 revenue grew 16.6% to ₹703cr; FY26 revenue grew 12.2% to ₹2,763cr. EBITDA margin normalized at 28.3%.
Call details
| Company | Dr. Lal Pathlabs Ltd |
|---|---|
| NSE symbol | LALPATHLAB |
| ISIN | INE600L01024 |
| Call | Q2 FY27 earnings call |
| Date | Wednesday, 4 November 2026 |
| Time | 6:00 PM IST |
| Length | 59 min |
| Audio | Our stream on YouTube ↗ |
Dr. Lal Pathlabs Ltd: key numbers
- Share price
- ₹2,045.00
- Market cap
- ₹34,325 Cr
- Revenue (annual)
- ₹2,763 Cr
- Net profit (annual)
- ₹504.8 Cr
- P/E (TTM)
- 58.8×Sector 53.8×
- Promoter holding
- 52.93%-0.26% QoQ
- FII holding
- 18.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Other calls on Wed, 4 Nov
Today's concalls →
Ended
Ended
Ended
Ended
Ended
Ended
Ended
Ended